179 related articles for article (PubMed ID: 11817317)
1. Prevention of catheter related infections in patients on CAPD.
Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
3. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
Ritzau J; Hoffman RM; Tzamaloukas AH
Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
5. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
[TBL] [Abstract][Full Text] [Related]
6. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
7. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
8. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
Al-Hwiesh AK; Abdul Rahman IS
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus infections in dialysis patients: focus on prevention.
Piraino B
ASAIO J; 2000; 46(6):S13-7. PubMed ID: 11110288
[TBL] [Abstract][Full Text] [Related]
10. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
12. Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis.
Araki Y; Hataya H; Ikeda M; Ishikura K; Honda M
Perit Dial Int; 2003; 23(3):267-9. PubMed ID: 12938828
[TBL] [Abstract][Full Text] [Related]
13. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients.
Pratt O
CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650
[TBL] [Abstract][Full Text] [Related]
14. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
16. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.
J Am Soc Nephrol; 1996 Nov; 7(11):2403-8. PubMed ID: 8959632
[TBL] [Abstract][Full Text] [Related]
17. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
Lim CT; Wong KS; Foo MW
Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
[TBL] [Abstract][Full Text] [Related]
19. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus CAPD-related infections are associated with nasal carriage.
Lye WC; Leong SO; van der Straaten J; Lee EJ
Adv Perit Dial; 1994; 10():163-5. PubMed ID: 7999818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]